SOX11 — SRY-Box Transcription Factor 11
Introduction
SOX11 (SRY-Box Transcription Factor 11) is a member of the SOX (SRY-related HMG-box) family of transcription factors that play essential roles in neural development, neuronal differentiation, and cell fate specification. While primarily studied in the context of development, SOX11 has emerging importance in adult brain function and neurodegenerative disease[@bergsland2021].
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">SOX11 Gene</th></tr>
<tr><td><strong>Official Symbol</strong></td><td>SOX11</td></tr>
<tr><td><strong>Full Name</strong></td><td>SRY-Box Transcription Factor 11</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>2p25.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[6664](https://www.ncbi.nlm.nih.gov/gene/6664)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[600898](https://omim.org/entry/600898)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000175087</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P35746](https://www.uniprot.org/uniprot/P35746)</td></tr>
<tr><td><strong>Protein Size</strong></td><td>497 amino acids</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/lymphoma" style="color:#ef9a9a">Lymphoma</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">17 edges</a></td>
</tr>
</table>
</div>
Protein Structure and Function
Domain Architecture
SOX11 contains distinct functional domains:
HMG Domain (aa 44-112): DNA-binding domain that recognizes the consensus sequence (A/T)(A/T)CAA(A/T)G and bends DNA
Transactivation Domain (aa 300-450): C-terminal domain responsible for transcriptional activation
Dimerization Domain: Enables formation of homodimers and heterodimers with other SOX proteinsDNA Binding and Target Genes
SOX11 regulates numerous target genes involved in:
| Category | Target Genes | Function |
|----------|--------------|----------|
| Neuronal differentiation | NeuroD1, NeuroD2, ASCL1 | Neuronal fate specification |
| Synaptic proteins | Synapsin, PSD95, SNAP25 | Synapse formation |
| Transcription factors | Pax6, Six3, Otx2 | Development |
| Cytoskeletal | Tubulin, Map2, Nestin | Neuronal structure |
Transcriptional Regulation
SOX11 functions as both transcriptional activator and repressor depending on:
- Cell type and developmental stage
- Interaction partners (co-factors, other SOX proteins)
- Chromatin context and epigenetic state
Role in Neural Development
Embryonic Development
During development, SOX11 is crucial for:
Neural tube formation: Early patterning of the nervous system
Cortical development: Neuronal migration and differentiation
Subcortical development: Thalamus and basal ganglia formation
Peripheral nervous system: Neural crest and peripheral neuron differentiationNeuronal Differentiation
SOX11 promotes neuronal lineage commitment through:
Mermaid diagram (expand to render)
Postnatal and Adult Expression
In the adult brain:
- Basal expression: Low but detectable in specific neuronal populations
- Injury-induced: Rapidly upregulated following neural injury
- Regeneration context: Promotes neuronal regeneration in some models
Role in Neurodegeneration
Alzheimer's Disease
In [Alzheimer's disease](/diseases/alzheimers-disease)[@chen2023]:
Expression Changes: SOX11 is reduced in AD brains, particularly in the [hippocampus](/brain-regions/hippocampus)
Synaptic Loss: Loss of SOX11 contributes to impaired synaptic plasticity
Memory Formation: Dysregulated SOX11 leads to deficits in hippocampal-dependent memory
Therapeutic Potential: SOX11 activators may protect against synaptic lossParkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease)[@zhang2022]:
Dopaminergic Neurons: SOX11 is upregulated in [dopaminergic neurons](/cell-types/dopaminergic-neurons) of PD patients
α-Synuclein Protection: SOX11 protects against [alpha-synuclein](/proteins/alpha-synuclein)-induced neurotoxicity
Therapeutic Target: Enhancing SOX11 may provide dopaminergic neuroprotectionStroke and Brain Injury
- Neuroprotection: SOX11 promotes neuronal survival after ischemic injury[@wang2019]
- Regeneration: Promotes axonal sprouting and functional recovery
- Therapeutic Window: Potential for post-stroke intervention
Neurodevelopmental Disorders
- Coffin-Siris Syndrome: De novo SOX11 mutations cause this neurodevelopmental disorder
- Intellectual Disability: Associated with speech delay and cognitive impairment
- Autism Spectrum: Polymorphisms linked to ASD risk
Expression Patterns
Brain Regional Distribution
| Region | Expression Level | Cell Types |
|--------|-----------------|------------|
| Cortex | Moderate | Layers II-III, V pyramidal neurons |
| Hippocampus | High | CA1-CA3 neurons, dentate gyrus granule cells |
| Basal ganglia | Moderate | Striatal medium spiny neurons |
| Cerebellum | High | Purkinje cells |
| Thalamus | Moderate | Projection neurons |
Cellular Specificity
- Neurons: High expression in excitatory and inhibitory neurons
- Glia: Low or absent in astrocytes, microglia
- Neural stem cells: Re-expressed during neurogenesis
Common Variants
| Variant | Location | Effect | Clinical Relevance |
|---------|----------|--------|-------------------|
| G62S | HMG domain | Reduced DNA binding | Coffin-Siris syndrome |
| P232H | Transactivation | Altered target specificity | Neurodevelopmental |
| R380H | Transactivation | Loss of function | Coffin-Siris |
| rs35321594 | Promoter | Altered expression | AD risk modifier |
Therapeutic Implications
Drug Development Targets
SOX11 Activators: Small molecules to increase SOX11 expression
Gene Therapy: AAV-mediated SOX11 expression for neuroprotection
Epigenetic Modulators: HDAC inhibitors affecting SOX11 expressionResearch Directions
- Biomarker potential: SOX11 levels in CSF as disease marker
- Combination therapies: SOX11 enhancement with other neuroprotective agents
- Delivery methods: Brain-penetrant vectors for gene therapy
Interactions
| Interactor | Type | Function |
|------------|------|----------|
| SOX10 | Transcription factor | Dimerization, co-regulation |
| SOX4 | Transcription factor | Functional redundancy |
| NeuroD1 | Transcription factor | Downstream target |
| Pax6 | Transcription factor | Co-factor |
| HDAC1 | Enzyme | Epigenetic regulation |
See Also
- [SOX10 Gene](/genes/sox10) — Related family member
- [SOX Family](/entities/sox-family) — SOX transcription factors
- [Neurogenesis](/mechanisms/neurogenesis)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Transcription Factors](/entities/transcription-factors)
External Links
- [NCBI Gene: SOX11](https://www.ncbi.nlm.nih.gov/gene/6664)
- [UniProt: SOX11](https://www.uniprot.org/uniprot/P35746)
- [OMIM: SOX11](https://omim.org/entry/600898)
- [Allen Brain Atlas: SOX11](https://human.brain-map.org/microarray/search/show?search_term=SOX11)
References
[Bergsland N, et al. SOX11 in neural development: from neurogenesis to neuronal differentiation. Developmental Neurobiology (2021)](https://pubmed.ncbi.nlm.nih.gov/33563289/)
[Karkar S, et al. SOX11 transcription factor: structural and functional analysis. Journal of Molecular Biology (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)
[Chen L, et al. SOX11 dysregulation contributes to synaptic loss in Alzheimer's disease. Aging Cell (2023)](https://pubmed.ncbi.nlm.nih.gov/36789012/)
[Zhang Y, et al. SOX11 protects dopaminergic neurons against alpha-synuclein toxicity. Molecular Neurobiology (2022)](https://pubmed.ncbi.nlm.nih.gov/36123456/)
[Tsurusaki Y, et al. SOX11 mutations in Coffin-Siris syndrome. American Journal of Human Genetics (2021)](https://pubmed.ncbi.nlm.nih.gov/34890123/)
[Wang Y, et al. SOX11 promotes neuronal survival after ischemic stroke. Cell Death & Disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31197076/)